Last reviewed · How we verify
Propadrine (PHENYLPROPANOLAMINE)
At a glance
| Generic name | PHENYLPROPANOLAMINE |
|---|---|
| Sponsor | Alpharma Us Pharms |
| Drug class | Indirectly Acting Sympathomimetic Amines |
| Target | Sodium-dependent noradrenaline transporter |
| Modality | Small molecule |
| Therapeutic area | Metabolic |
| Phase | FDA-approved |
| First approval | 2000 |
Approved indications
- Allergic conjunctivitis
- Allergic rhinitis
- Common cold
- Cough
- Influenza-like symptoms
- Nasal congestion
- Nasal discharge
- Rhinitis
- Seasonal allergic rhinitis
- Sinus headache
- Sneezing
- Vasomotor rhinitis
Common side effects
Drug interactions
- rasagiline
- tranylcypromine
Key clinical trials
- Effect of Nicotinamide Riboside on Ketosis, Fat Oxidation & Metabolic Rate (NA)
- Dietary Manipulation of the Microbiome-metabolomic Axis for Mitigating GVHD in Allo HCT Patients (PHASE2)
- Ketogenic Diet Interventions in Parkinson's Disease: Safeguarding the Gut Microbiome (NA)
- A Study to Explore if Long-term Use of Mucinex Can Help With Symptoms in Patients With Stable Chronic Bronchitis. (PHASE4)
- TReating Incontinence for Underlying Mental and Physical Health (PHASE4)
- Dual Therapy With Vonoprazan Plus Amoxicillin or Doxycycline Versus Bismuth Quadruple Therapy for Helicobacter Pylori Eradication. (NA)
- Expanded Access Program for Tiratricol in Patients With Monocarboxylate Transporter 8 Deficiency
- Triac Trial II in MCT8 Deficiency Patients (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |